AU2001220270B2 - Method for cell adhesion and wound healing - Google Patents

Method for cell adhesion and wound healing Download PDF

Info

Publication number
AU2001220270B2
AU2001220270B2 AU2001220270A AU2001220270A AU2001220270B2 AU 2001220270 B2 AU2001220270 B2 AU 2001220270B2 AU 2001220270 A AU2001220270 A AU 2001220270A AU 2001220270 A AU2001220270 A AU 2001220270A AU 2001220270 B2 AU2001220270 B2 AU 2001220270B2
Authority
AU
Australia
Prior art keywords
pig
fas
domains
cell adhesion
wound healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001220270A
Other languages
English (en)
Other versions
AU2001220270A1 (en
Inventor
In-San Kim
Jung-Eun Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regen Biotech Inc
Original Assignee
Regen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regen Biotech Inc filed Critical Regen Biotech Inc
Publication of AU2001220270A1 publication Critical patent/AU2001220270A1/en
Application granted granted Critical
Publication of AU2001220270B2 publication Critical patent/AU2001220270B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2001220270A 2000-05-13 2000-12-08 Method for cell adhesion and wound healing Ceased AU2001220270B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2000-0025662A KR100385293B1 (ko) 2000-05-13 2000-05-13 βｉｇ-ｈ3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법
KR2000/25662 2000-05-13
PCT/KR2000/001428 WO2001087327A1 (en) 2000-05-13 2000-12-08 Method for cell adhesion and wound healing

Publications (2)

Publication Number Publication Date
AU2001220270A1 AU2001220270A1 (en) 2002-02-14
AU2001220270B2 true AU2001220270B2 (en) 2004-09-30

Family

ID=19668565

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001220270A Ceased AU2001220270B2 (en) 2000-05-13 2000-12-08 Method for cell adhesion and wound healing
AU2027001A Withdrawn AU2027001A (en) 2000-05-13 2000-12-08 Method for cell adhesion and wound healing

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2027001A Withdrawn AU2027001A (en) 2000-05-13 2000-12-08 Method for cell adhesion and wound healing

Country Status (12)

Country Link
US (2) US7396682B2 (enExample)
EP (1) EP1282434B1 (enExample)
JP (1) JP3795805B2 (enExample)
KR (1) KR100385293B1 (enExample)
CN (1) CN1209165C (enExample)
AT (1) ATE446765T1 (enExample)
AU (2) AU2001220270B2 (enExample)
CA (1) CA2409506A1 (enExample)
DE (1) DE60043238D1 (enExample)
IL (2) IL152410A0 (enExample)
RU (1) RU2234937C2 (enExample)
WO (1) WO2001087327A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258260B2 (en) * 1970-02-11 2012-09-04 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
KR100378949B1 (ko) * 2000-05-13 2003-04-08 주식회사 리젠 바이오텍 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체
AU2002348583B2 (en) * 2002-04-19 2006-12-07 Regen Biotech, Inc. The method for measuring the amount of betaig-h3 protein and diagnostic kit using the same
US20080274955A1 (en) * 2004-04-13 2008-11-06 Kyungpook National University Industry Academic Cooperation Foundation Novel Use of a Polypeptide Comprising Fas-1 Domain
KR100635540B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
RU2288663C1 (ru) * 2005-05-03 2006-12-10 Государственное учреждение Самарский государственный медицинский университет Способ лечения посттравматического остеомиелита
RU2458069C2 (ru) * 2007-01-05 2012-08-10 Хеликс Байомедикс Инк. Выделенный пептид для усиления ранозаживляющей активности кератиноцитов, композиция для заживления ран у млекопитающего и лекарственное средство для применения при заживлении ран у млекопитающего
JP2012012344A (ja) * 2010-07-01 2012-01-19 Japan Health Science Foundation 創傷治癒剤
CN108586584A (zh) * 2018-05-03 2018-09-28 杭州史迪姆生物科技有限公司 功能多肽及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444164A (en) * 1992-02-05 1995-08-22 Bristol-Myers Squibb Company TGF-β induced gene
WO1996001102A1 (en) * 1994-07-01 1996-01-18 Advanced Tissue Sciences Factor to grow tissue ex vivo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983581A (en) * 1988-05-20 1991-01-08 Institute Of Molecular Biology, Inc. Wound healing composition of IGF-I and TGF-β
DE69133087T2 (de) * 1990-05-30 2003-04-03 Institute Of Molecular Biology Inc., Boston Kombination aus IGF-I und TGF-beta zur Knochenregenerierung
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
KR100378949B1 (ko) * 2000-05-13 2003-04-08 주식회사 리젠 바이오텍 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444164A (en) * 1992-02-05 1995-08-22 Bristol-Myers Squibb Company TGF-β induced gene
WO1996001102A1 (en) * 1994-07-01 1996-01-18 Advanced Tissue Sciences Factor to grow tissue ex vivo

Also Published As

Publication number Publication date
IL200132A0 (en) 2010-04-15
CN1209165C (zh) 2005-07-06
ATE446765T1 (de) 2009-11-15
CA2409506A1 (en) 2001-11-22
DE60043238D1 (de) 2009-12-10
JP2004521605A (ja) 2004-07-22
US20100331253A9 (en) 2010-12-30
AU2027001A (en) 2001-11-26
US7396682B2 (en) 2008-07-08
WO2001087327A1 (en) 2001-11-22
IL152410A0 (en) 2003-05-29
EP1282434B1 (en) 2009-10-28
RU2002133463A (ru) 2004-03-27
KR20010104176A (ko) 2001-11-24
US20040052767A1 (en) 2004-03-18
RU2234937C2 (ru) 2004-08-27
US20080214463A1 (en) 2008-09-04
EP1282434A1 (en) 2003-02-12
JP3795805B2 (ja) 2006-07-12
CN1452493A (zh) 2003-10-29
KR100385293B1 (ko) 2003-05-23
EP1282434A4 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
US20100331253A9 (en) Method for cell adhesion and wound healing
Ehrenreich et al. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes
Rogelj et al. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells.
JPH06509791A (ja) 血管形成抑制のための方法と組成物
KR101179678B1 (ko) 성장인자 복합체 및 세포 이동 및 성장의 조절
JPH06506470A (ja) ＴＧＦ−β１／β２：新規なキメラトランスフォーミング増殖因子−β
US20080015150A1 (en) Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity
AU2001220270A1 (en) Method for cell adhesion and wound healing
US6399584B1 (en) Pharmaceutical composition containing ezrin mutated on tyrosine 353
WO2007023875A1 (ja) ラミニン５を利用した間葉系幹細胞の培養技術
AU2001220262A1 (en) Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
CN100513418C (zh) 促进细胞粘附和扩散的肽、其片段和衍生物
KR100382042B1 (ko) 창상 치료를 위한 βｉｇ-ｈ3 단백질 또는 그의 일부도메인을 포함하는 약학적 조성물
Gospodarowicz University of California, Medical Center San Francisco, CA
HK1232554A1 (en) Vitronectin:keratinocyte growth factor chimeras
HK1070290B (en) Growth factor complex
JP2003093064A (ja) ラミニンα３鎖の改変体
HK1070290A1 (en) Growth factor complex
JP2001078777A (ja) 新規蛋白質及びその製造方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired